Long day for mom but a good one. She has been offered, and has accepted, the opportunity to participate in a clinical trial. Her treatment will be a combination of Avastin (bevacizumab), Camptosar (CPT11), and carboplatin. She will be treated every two weeks by her current doctor in Charlotte, who apparently interfaces regularly with the folks at Duke.
Most importantly, she feels very comfortable with the competence of the people and the direction of her treatment as outlined by the Duke staff. Tomorrow, another meeting at Duke to discuss the quality of life issues that will accompany the clinical trial program, and then presumably back home to Charlotte.
Best to all, Ted
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment